The Federal Office for Safety in Health Care has been informed by the ECDC (European Centre for Disease Prevention and Control) that in Hungary, in addition to the regions already announced, confirmed human WNV infections have been recorded in the Békés region.

The Federal Office for Safety in Health Care has been informed by the ECDC (European Centre for Disease Prevention and Control) that human WNV infections have been recorded in Toledo in Spain, in addition to the regions already announced.

The Federal Office for Safety in Health Care has been informed by the ECDC (European Centre for Disease Prevention and Control) that in France, in addition to the regions already announced, human WNV infections have been recorded in the Haute-Corse region.

The Federal Office for Safety in Health Care has been informed by the ECDC (European Centre for Disease Prevention and Control) that confirmed human WNV infections have been recorded in Croatia in the regions of Brod-Posavina, Osijek-Baranja, Vukovar-Srijem and Zagreb.

The Federal Office for Safety in Health Care was informed by the Cypriot authority that a WNV infection was recorded in a blood donor by NAT testing in Cyprus.

The Federal Office for Safety in Health Care has been informed by the Italian authorities that, in addition to the regions already announced, confirmed human dengue virus cases have been recorded in the province of Latina.

The Federal Office for Safety in Health Care has been informed by the ECDC (European Centre for Disease Prevention and Control) that a confirmed human WNV infection has been recorded in Northern Macedonia, in the Skopsi region.

The Federal Office for Safety in Health Care was informed by the Danish authority that it had been informed by the Danish tissue bank European Sperm Bank that a one-year-old male offspring of the donor had been diagnosed with infantile cystinosis.

The Federal Office for Safety in Health Care has been informed by the Danish authority that it has been informed by the Danish tissue bank Cryos International-Aarhus (DK257551) that a 16p13.11 duplication was detected during prenatal screening of a donor-conceived fetus.

The Federal Office for Safety in Health Care has been informed by the French authority that measurement deviations have occurred with the medical device for whole blood collection TAT (top and top) FQE614B (equipped with an LXT leukocyte reduction filter) from the medical device manufacturer Macopharma.